Sara Le - Oxford Nanopore VP Marketing

All Insiders . USA . 
Stock . Oxford Nanopore Technologies . Stakeholders . Insider . Sara Le
ONTTF Stock  USD 1.72  0.10  5.49%   

Insider

Sara Le is VP Marketing of Oxford Nanopore Technologies
Phone44 84 5034 7900
Webhttps://nanoporetech.com

Oxford Nanopore Management Efficiency

The company has return on total asset (ROA) of (0.1396) % which means that it has lost $0.1396 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2843) %, meaning that it generated substantial loss on money invested by shareholders. Oxford Nanopore's management efficiency ratios could be used to measure how well Oxford Nanopore manages its routine affairs as well as how well it operates its assets and liabilities.
Oxford Nanopore Technologies has accumulated 9.5 M in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Oxford Nanopore Tech has a current ratio of 8.34, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Oxford Nanopore until it has trouble settling it off, either with new capital or with free cash flow. So, Oxford Nanopore's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Oxford Nanopore Tech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Oxford to invest in growth at high rates of return. When we think about Oxford Nanopore's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Scott ThomasSeer Inc
51
Blake SalisburyInnovent Biologics
N/A
Todd RearickQuantumSi
N/A
DeChao YuInnovent Biologics
59
Ioana HoneLineage Cell Therapeutics
N/A
Marissa DixonSeer Inc
N/A
ACIS ACSGenscript Biotech
42
Pr MDNurix Therapeutics
N/A
MD MPHMediciNova
56
Gwenn HansenNurix Therapeutics
54
Yong MDInnovent Biologics
54
Min LiuInnovent Biologics
N/A
John KuriyanNurix Therapeutics
N/A
Prof ShairNuvalent
56
Changshou GaoInnovent Biologics
N/A
William AnnettLineage Cell Therapeutics
70
Joe LawsSeer Inc
N/A
Patrick SchneiderQuantumSi
N/A
Karen PossematoSeer Inc
N/A
John CPAMediciNova
N/A
Serafim BatzoglouSeer Inc
N/A
Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom. Oxford Nanopore operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 900 people. Oxford Nanopore Technologies [ONTTF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Return On Equity-0.28
Return On Asset-0.14

Oxford Nanopore Tech Leadership Team

Elected by the shareholders, the Oxford Nanopore's board of directors comprises two types of representatives: Oxford Nanopore inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oxford. The board's role is to monitor Oxford Nanopore's management team and ensure that shareholders' interests are well served. Oxford Nanopore's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oxford Nanopore's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tim Cowper, CFO Director
Sara Le, VP Marketing
Sarah Lapworth, VP HR
Jordan Herman, Sr Counsel
Richard Compton, VP Operations
John Schoellerman, Sr Relations
Pr Bayley, CoFounder Board
Rhodri Davies, VP Operations
Gordon Sanghera, CEO CoFounder
Clive Brown, CTO Director

Oxford Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Oxford Nanopore a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.28
Return On Asset-0.14
Profit Margin(0.78) %
Operating Margin(0.72) %
Current Valuation1.7 B
Shares Outstanding825.96 M
Shares Owned By Insiders34.06 %
Shares Owned By Institutions40.78 %
Price To Book2.69 X
Price To Sales12.58 X

Currently Active Assets on Macroaxis

EBRCentrais Electricas Brasileiras
HEHawaiian Electric Industries
VFCVF Corporation
BVHMFVistry Group PLC
SSentinelOne

Other Information on Investing in Oxford Pink Sheet

Oxford Nanopore financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Nanopore security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY